The CNS GLP- 1 receptors are not necessary for the physiological regulation of blood glucose levels by endogenous GLP- 1 or the pharmacological control of glucose homeostasis that depends on GLP- 1 receptors, although further research is needed to investigate the possible role of GLP- 1 receptors expressed outside the beta cell, including within the enteric and peripheral nervous systems, in improving beta cell function through enteral glucose mediation [70, 84]
Both drugs are being developed by Novo Nordisk, likely reflecting a portfolio strategy: CagriSema as the first-to-market injectable combination, and amycretin as a follow-on oral option for patients who prefer pills
Knowing what to expect can help you manage your treatment more effectively
This gradual approach helps manage adverse events and makes it easier for patients to stay on the medication long term
Clinician-framed advice therefore, includes slower titration, medication review, and tailored behavioral strategies to reduce triggers and allow adaptation